A new study has found that the protein RBMXL2 is crucial for the development of sperm in mice, which could lead to potential treatments for male infertility. The study, conducted by researchers at the University of California, Los Angeles (UCLA) and published in the journal Nature Communications, found that mice that had been genetically engineered to lack the gene for the RBMXL2 protein had significantly impaired sperm production. The findings suggest that this protein could be a potential target for the development of treatments for male infertility. This could be a gamechanger for people living with this condition.

Read Full Article Here

source: Phys.org